Impact of Changes in Human Airway Epithelial Cellular Composition and Differentiation on SARS-CoV-2 Infection Biology

J Innate Immun. 2023;15(1):562-580. doi: 10.1159/000530374. Epub 2023 Mar 25.

Abstract

The consequences of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can range from asymptomatic to fatal disease. Variations in epithelial susceptibility to SARS-CoV-2 infection depend on the anatomical location from the proximal to distal respiratory tract. However, the cellular biology underlying these variations is not completely understood. Thus, air-liquid interface cultures of well-differentiated primary human tracheal and bronchial epithelial cells were employed to study the impact of epithelial cellular composition and differentiation on SARS-CoV-2 infection by transcriptional (RNA sequencing) and immunofluorescent analyses. Changes of cellular composition were investigated by varying time of differentiation or by using specific compounds. We found that SARS-CoV-2 primarily infected not only ciliated cells but also goblet cells and transient secretory cells. Viral replication was impacted by differences in cellular composition, which depended on culturing time and anatomical origin. A higher percentage of ciliated cells correlated with a higher viral load. However, DAPT treatment, which increased the number of ciliated cells and reduced goblet cells, decreased viral load, indicating the contribution of goblet cells to infection. Cell entry factors, especially cathepsin L and transmembrane protease serine 2, were also affected by differentiation time. In conclusion, our study demonstrates that viral replication is affected by changes in cellular composition, especially in cells related to the mucociliary system. This could explain in part the variable susceptibility to SARS-CoV-2 infection between individuals and between anatomical locations in the respiratory tract.

Keywords: Cell culture; Cellular composition; Human airway epithelial cells; Infection biology; SARS-CoV-2.

MeSH terms

  • Biology
  • COVID-19*
  • Epithelial Cells
  • Humans
  • Respiratory System
  • SARS-CoV-2

Grants and funding

This study was supported by a COVID-19 MKMD grant from The Netherlands Organization for Health Research and Development (ZonMw) and the Dutch Society for the Replacement of Animal Testing (Stichting Proefdiervrij) (Grant #114025007). C.S.-B. was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES) (process no. 88881.171440/2018-01), Ministry of Education, Brazil. Part of this research was supported by the Leiden University Fund (LUF), the Bontius Foundation, and donations from the crowd-funding initiative “wake up to corona.” This study has also received funding from the European Union’s Horizon 2020 research and innovation program under Grant No. 10100362 (the SCORE project). Part of RNA-Seq and analysis was supported by a RSEOH-CAG Rapid Response Research Initiative and a RSEOH-CAG 2021 Extension Grant. Collection of primary human tracheal epithelial cells was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (Ta 275/7-1 and Ta 275/8-1) to C.T.